Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1241-1250 of 1,779) with videos related to

Pageof 178
Sort By:
Mabs|December 11, 2025
Conformation-aware structure prediction of antigen-recognizing immune proteinsFrédéric A Dreyer, Jan Ludwiczak, Karolis Martinkus, et al.
Mabs|December 12, 2025
Beyond sequence similarity: ML-powered identification of pHLA off-targets for TCR-mimic antibodies using high throughput binding kineticsAlexander Sinclair, Stefan Krämer, Christoph Reinhart, et al.
Mabs|November 6, 2025
Optimizing efficacy and safety of T cell bispecific antibodies: the interdependence of CD3 and tumor antigen binder affinities in FOLR1 and CEACAM5 2 + 1 TCBsOmar Abdelmotaleb, Anneliese Schneider, Inja Waldhauer, et al.
Mabs|July 8, 2025
Development and preclinical characterization of AMG 329: a human antibody neutralizing FLT3 ligandAnnie Lau-Kilby, Michele Gunsior, Agata Bartczak, et al.
Mabs|July 14, 2025
Tuning antibody stability and function by rational designs of framework mutationsJoseph C F Ng, Alicia Chenoweth, Maria Laura De Sciscio, et al.
Mabs|July 15, 2025
Trispecific SEED antibodies engineered for neutrophil-mediated cell killingVeronica Natale, Gergely Heves, Katharina Stadlbauer, et al.
Mabs|October 13, 2025
A comprehensive strategy for pandemic preparedness with neutralizing monoclonal antibodiesChristian Marx, Ralf Piotrowiak, Thomas Schirrmann, et al.
Mabs|September 18, 2025
ManNAc attenuates Man5 glycoform abundance through GNE-mediated metabolic channeling of UDP-GlcNAc to N-glycosylation modifications via CMP-Neu5Ac biosynthesisRuiqiang Sun, Miaomiao Chai, Jiahao Man, et al.
Mabs|May 21, 2025
Development and characterization of AD-214, an anti-CXCR4 i-body-Fc fusion for the treatment of idiopathic pulmonary fibrosisJason P Lynch, Louise Organ, Khamis Tomusange, et al.
Mabs|July 22, 2025
Analytical development and application of a targeted liquid chromatography-tandem mass spectrometry assay for chimeric aducanumabEmma H Doud, Kasi Hansen, Kathryn A Haynes, et al.
Pageof 178

Showing results (1241-1250 of 1,779) with videos related to

Sort By:
Pageof 178
Mabs|December 11, 2025
Conformation-aware structure prediction of antigen-recognizing immune proteinsFrédéric A Dreyer, Jan Ludwiczak, Karolis Martinkus, et al.
Mabs|December 12, 2025
Beyond sequence similarity: ML-powered identification of pHLA off-targets for TCR-mimic antibodies using high throughput binding kineticsAlexander Sinclair, Stefan Krämer, Christoph Reinhart, et al.
Mabs|November 6, 2025
Optimizing efficacy and safety of T cell bispecific antibodies: the interdependence of CD3 and tumor antigen binder affinities in FOLR1 and CEACAM5 2 + 1 TCBsOmar Abdelmotaleb, Anneliese Schneider, Inja Waldhauer, et al.
Mabs|July 8, 2025
Development and preclinical characterization of AMG 329: a human antibody neutralizing FLT3 ligandAnnie Lau-Kilby, Michele Gunsior, Agata Bartczak, et al.
Mabs|July 14, 2025
Tuning antibody stability and function by rational designs of framework mutationsJoseph C F Ng, Alicia Chenoweth, Maria Laura De Sciscio, et al.
Mabs|July 15, 2025
Trispecific SEED antibodies engineered for neutrophil-mediated cell killingVeronica Natale, Gergely Heves, Katharina Stadlbauer, et al.
Mabs|October 13, 2025
A comprehensive strategy for pandemic preparedness with neutralizing monoclonal antibodiesChristian Marx, Ralf Piotrowiak, Thomas Schirrmann, et al.
Mabs|September 18, 2025
ManNAc attenuates Man5 glycoform abundance through GNE-mediated metabolic channeling of UDP-GlcNAc to N-glycosylation modifications via CMP-Neu5Ac biosynthesisRuiqiang Sun, Miaomiao Chai, Jiahao Man, et al.
Mabs|May 21, 2025
Development and characterization of AD-214, an anti-CXCR4 i-body-Fc fusion for the treatment of idiopathic pulmonary fibrosisJason P Lynch, Louise Organ, Khamis Tomusange, et al.
Mabs|July 22, 2025
Analytical development and application of a targeted liquid chromatography-tandem mass spectrometry assay for chimeric aducanumabEmma H Doud, Kasi Hansen, Kathryn A Haynes, et al.
Pageof 178